Article

Discovery and validation of non-canonical antigens for Hepatocellular Carcinoma immunotherapy

2025-06-09

Abstract excerpt

Hepatocellular carcinoma (HCC) is a highly prevalent and lethal form of liver cancer marked by high rates of tumor recurrence, posing substantial challenges to primary treatment options such as surgical resection and liver transplantation. Immunotherapy, which leverages T-cell-mediated recognition of tumor-specific antigens, has emerged as a promising alternative therapeutic strategy. While proteogenomics and ribo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bc460be5-b9d4-561a-a1ce-0e1c2ecfea67
DOI: 10.1101/2025.06.08.25328714

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Discovery and validation of non-canonical antigens for Hepatocellular Carcinoma immunotherapyDOI 10.1101/2025.06.08.25328714Read

Non-canonical ORFs are an important source of tumor-specific antigens in a liver cancer meta-cohortSemantic proximity Read

Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancerSemantic proximity Read

Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomesSemantic proximity Read

Most non-canonical proteins uniquely populate the proteome or immunopeptidomeSemantic proximity Read

CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteinsSemantic proximity Read

Decoding Neoantigen-encoding Tumor-Specific Transcripts Unveils a Shared Target Reservoir for Immunotherapy in Hepatocellular CarcinomaSemantic proximity Read

Integrated Proteogenomic Deep Sequencing and Analytics Accurately Identify Non-Canonical Peptides in Tumor ImmunopeptidomesSemantic proximity Read

A proteogenomic approach to discover novel lncRNA-derived peptides and their potential clinical utility in hepatocellular carcinomaSemantic proximity Read

NovumRNA: accurate prediction of non-canonical tumor antigens from RNA sequencing dataSemantic proximity Read

Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptidesSemantic proximity Read

Pancreatic cancer–restricted cryptic antigens are targets for T cell recognitionSemantic proximity Read

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinomaSemantic proximity Read